In India, Mounjaro is approved for weight loss as well, if your BMI is above 30, or if your BMI is 27 and above and you have clinical conditions associated with obesity
Poll: 1 in 8 adults say they are currently taking a GLP-1 drug for weight loss, diabetes or another condition, even as half say the drugs are difficult to afford
The FDA's staff reviewers had last month said there is little evidence to support the safety and effectiveness of these peptides for their intended uses and flagged a lack of adequate human clinical trials, in contrast to Kennedy's public support
(Lausanne) 10, 110
These products are not for human consumption, veterinary use, or any application involving living organisms, including but not limited to diagnostic, therapeutic, or recreational purposes